Biochemical and biophysical research communications

Shape of Cas12a's bridge helix affects how well it cuts target DNA and its tendency to cut off-target DNA

Updated

Abstract

Proline substitutions in Cas12a significantly reduce its ability to cleave on-target DNA while nearly eliminating cleavage of mismatched targets.

  • CRISPR-Cas systems utilize crRNA to guide Cas nucleases for immune defense and genome editing.
  • The bridge helix (BH) of Cas12a is crucial for its conformational changes necessary for DNA cleavage.
  • Alanine substitutions in the BH enhance the cleavage efficiency of Cas12a but reduce its discrimination against DNA mismatches.
  • Proline substitutions decrease on-target cleavage efficiency but greatly diminish the cleavage of mismatched targets.
  • These findings suggest that adjusting the helicity of the BH may improve the specificity of Cas12a in gene editing.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:There are two approved US patents on FnoCas12a BH (US11459552B2 and US12163166B2). Other than that, the authors declare no other competing financial interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free